140 related articles for article (PubMed ID: 11518070)
1. Effects of hyperforin on the fluidity of brain membranes.
Eckert GP; Müller WE
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S22-5. PubMed ID: 11518070
[TBL] [Abstract][Full Text] [Related]
2. Hyperforin modifies neuronal membrane properties in vivo.
Eckert GP; Keller JH; Jourdan C; Karas M; Volmer DA; Schubert-Zsilavecz M; Müller WE
Neurosci Lett; 2004 Sep; 367(2):139-43. PubMed ID: 15331138
[TBL] [Abstract][Full Text] [Related]
3. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
4. St John's wort extract influences membrane fluidity and composition of phosphatidylcholine and phosphatidylethanolamine in rat C6 glioblastoma cells.
Keksel N; Bussmann H; Unger M; Drewe J; Boonen G; Häberlein H; Franken S
Phytomedicine; 2019 Feb; 54():66-76. PubMed ID: 30668384
[TBL] [Abstract][Full Text] [Related]
5. Cellular neurobiology of hyperforin.
Bouron A
Phytother Res; 2024 Feb; 38(2):636-645. PubMed ID: 37963759
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
7. Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat.
Chatterjee S; Filippov V; Lishko P; Maximyuk O; Nöldner M; Krishtal O
Life Sci; 1999; 65(22):2395-405. PubMed ID: 10597894
[TBL] [Abstract][Full Text] [Related]
8. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
[TBL] [Abstract][Full Text] [Related]
9. Current St John's wort research from mode of action to clinical efficacy.
Müller WE
Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
[TBL] [Abstract][Full Text] [Related]
10. Hyperforin stimulates intracellular calcium mobilisation and enhances extracellular acidification in DDT1-MF2 smooth muscle cells.
Koch E; Chatterjee SS
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S70-3. PubMed ID: 11518080
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
[TBL] [Abstract][Full Text] [Related]
12. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
[TBL] [Abstract][Full Text] [Related]
13. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.
Singer A; Wonnemann M; Müller WE
J Pharmacol Exp Ther; 1999 Sep; 290(3):1363-8. PubMed ID: 10454515
[TBL] [Abstract][Full Text] [Related]
14. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
[TBL] [Abstract][Full Text] [Related]
15. Hyperforin--antidepressant activity by a novel mechanism of action.
Müller WE; Singer A; Wonnemann M
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S98-102. PubMed ID: 11518085
[TBL] [Abstract][Full Text] [Related]
16. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
[TBL] [Abstract][Full Text] [Related]
17. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
Butterweck V; Winterhoff H; Herkenham M
Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of the dicyclohexylammonium salt of hyperforin on interleukin-6 release in different experimental models.
Gobbi M; Moia M; Funicello M; Riva A; Morazzoni P; Mennini T
Planta Med; 2004 Jul; 70(7):680-2. PubMed ID: 15303261
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.
Wonnemann M; Singer A; Müller WE
Neuropsychopharmacology; 2000 Aug; 23(2):188-97. PubMed ID: 10882845
[TBL] [Abstract][Full Text] [Related]
20. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
